Follow
Obdulia Rabal
Title
Cited by
Cited by
Year
The CHEMDNER corpus of chemicals and drugs and its annotation principles
M Krallinger, O Rabal, F Leitner, M Vazquez, D Salgado, Z Lu, R Leaman, ...
Journal of cheminformatics 7 (1), S2, 2015
3522015
Information retrieval and text mining technologies for chemistry
M Krallinger, O Rabal, A Lourenco, J Oyarzabal, A Valencia
Chemical reviews 117 (12), 7673-7761, 2017
2802017
Overview of the BioCreative VI chemical-protein interaction Track
M Krallinger, O Rabal, SA Akhondi
Proceedings of the BioCreative VI Workshop. Bethesda, MD, USA, 141-146, 2017
2662017
CHEMDNER: The drugs and chemical names extraction challenge
M Krallinger, F Leitner, O Rabal, M Vazquez, J Oyarzabal, A Valencia
Journal of cheminformatics 7 (1), S1, 2015
2542015
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
E San José-Enériz, X Agirre, O Rabal, A Vilas-Zornoza, JA Sanchez-Arias, ...
Nature communications 8, 15424, 2017
1452017
APIF: a new interaction fingerprint based on atom pairs and its application to virtual screening
VI Pérez-Nueno, O Rabal, JI Borrell, J Teixidó
Journal of chemical information and modeling 49 (5), 1245-1260, 2009
1172009
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases
W Link, J Oyarzabal, BG Serelde, MI Albarran, O Rabal, A Cebriá, ...
Journal of Biological Chemistry, jbc. M109. 038984, 2009
1012009
Dual targeting of histone methyltransferase G9a and DNA‐methyltransferase 1 for the treatment of experimental hepatocellular carcinoma
M Bárcena‐Varela, S Caruso, S Llerena, G Álvarez‐Sola, I Uriarte, ...
Hepatology, 2018
1002018
A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer’s disease mice
M Cuadrado-Tejedor, C Garcia-Barroso, JA Sánchez-Arias, O Rabal, ...
Neuropsychopharmacology 42 (2), 524, 2017
992017
Comparison of Ligand-Based and Receptor-Based Virtual Screening of HIV Entry Inhibitors for the CXCR4 and CCR5 Receptors Using 3D Ligand Shape Matching and Ligand− Receptor Docking
VI Pérez-Nueno, DW Ritchie, O Rabal, R Pascual, JI Borrell, J Teixidó
Journal of chemical information and modeling 48 (3), 509-533, 2008
892008
Design, synthesis, and biological evaluation of first-in-class dual acting histone deacetylases (HDACs) and phosphodiesterase 5 (PDE5) inhibitors for the treatment of Alzheimer …
O Rabal, JA Sánchez-Arias, M Cuadrado-Tejedor, I de Miguel, ...
Journal of medicinal chemistry 59 (19), 8967-9004, 2016
832016
Overview of the chemical compound and drug name recognition (CHEMDNER) task
M Krallinger, F Leitner, O Rabal, M Vazquez, J Oyarzabal, A Valencia
BioCreative challenge evaluation workshop 2, 2, 2013
762013
Overview of the CHEMDNER patents task
M Krallinger, O Rabal, A Lourenco, MP Perez, GP Rodriguez, M Vazquez, ...
Proceedings of the fifth BioCreative challenge evaluation workshop, 63-75, 2015
652015
Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach
J Oyarzabal, N Zarich, MI Albarran, I Palacios, M Urbano-Cuadrado, ...
Journal of medicinal chemistry 53 (18), 6618-6628, 2010
612010
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the …
O Rabal, JA Sánchez-Arias, M Cuadrado-Tejedor, I de Miguel, ...
European journal of medicinal chemistry 150, 506-524, 2018
572018
In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding
O Rabal, F Pastor, H Villanueva, MM Soldevilla, S Hervas-Stubbs, ...
Molecular Therapy-Nucleic Acids 5, 2016
482016
Design, synthesis and activity as acid ceramidase inhibitors of 2-oxooctanoyl and N-oleoylethanolamine analogues
S Grijalvo, C Bedia, G Triola, J Casas, A Llebaria, J Teixidó, O Rabal, ...
Chemistry and physics of lipids 144 (1), 69-84, 2006
482006
Imidazo[1,2-a]pyrazines as novel PI3K inhibitors
SM González, AI Hernández, C Varela, S Rodríguez-Arístegui, ...
Bioorganic & medicinal chemistry letters 22 (5), 1874-1878, 2012
422012
Discovery of reversible DNA methyltransferase and lysine methyltransferase G9a inhibitors with antitumoral in vivo efficacy
O Rabal, E San José-Enériz, X Agirre, JA Sánchez-Arias, A Vilas-Zornoza, ...
Journal of medicinal chemistry 61 (15), 6518-6545, 2018
392018
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
MM Soldevilla, S Hervas, H Villanueva, T Lozano, O Rabal, J Oyarzabal, ...
PloS one 12 (9), e0185169, 2017
372017
The system can't perform the operation now. Try again later.
Articles 1–20